RARE EPS Estimates
Ultragenyx Pharmaceutical Inc.
$15.07
+$0.53(+3.65%)
33
Overall
40
Value
10
Tech
50
Quality
Market Cap
$1.43B
Volume
2.98M
52W Range
$12.73 - $39.89
Target Price
$25.90
RARE EPS estimates: the consensus estimate for Ultragenyx Pharmaceutical Inc.'s current fiscal year is -$3.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RARE EPS Estimates
- EPS estimate, current quarter
- $-0.87
- EPS estimate, next quarter
- $-0.16
- EPS estimate, current year
- $-3.97
- EPS estimate, next year
- $-0.28
- EPS growth, 3-year
- +16.79%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.83 |
| 2024 | $-6.29 |
| 2023 | $-8.25 |
| 2022 | $-10.12 |
| 2021 | $-6.70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $15.07 | +3.6% | 2.98M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW